GoldenGolden
Advanced Search
Okairos

Okairos

Okairos is a Basel-Stadt-based company founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese and Stefano Colloca.

Fully integrated into GlaxoSmithKline since 2013, Okairos from Basel developed T-cell based vaccines for major infectious diseases such as malaria, hepatitis C, HIV, and Ebola.

Timeline

September 14, 2010
Okairos raises a $20,500,000 series B round from Boehringer Ingelheim Venture Fund and Versant Ventures.
March 2007
Okairos raises a $8,608,428 series A round from BioMedPartners, Life Sciences Partners and Novartis Venture Fund.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.